RE: RE: Lighten up Zep Zep; If there was a tire that was safe at any temperature and whose performance characteristics remained constant then yes we could debate which tire was best.
Solvency is no longer the pressing issue it was a year and a half back. If you recall BNC had maxed out their credit and was still footing the bills for the trials alone. At their burn rate ,by my calculations, they had til March 09 , to get a deal done or bring in new financing. Somehow they stretched it out and we know the story from July on. However several people were scorched on this board for breeching that subject . Lorne was one I recall. They are now in a much more stable fiscal position and have shown that they have a management who will do what it takes to weather the storm. On most fronts BNC is looking to break out. The Vaccine Manufacturing Centre is progressing and hopefully will be licensed on time to allow a federally mandated and subsidized vaccine program that is being discussed. We are building out on their dime. To be repaid later , I realize. So a big no to solvency as a concern..The only problematic issues at this time are coming from the U.S. The foot dragging regarding a conditional license for Econiche and Endo's non communication regarding Urocidin results and its decision to depart from the FDA approved p3b trial with no explanation.. I know the answers may be coming soon. I am just getting tired of being treated like a mushroom..Kept in the dark and fed bullsh*t. Dusty11